A comprehensive view of Gene Therapy & Regenerative Medicine. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
US Patent Issued to ELI LILLY and Co. on April 23 for "Compounds useful for inhibiting RET kinase" (Colorado, Montana Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to REGENERON PHARMACEUTICALS on April 23 for "Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy" (New York Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Humanized IL-4 and IL-4RAlpha animals" (New York, California Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Antigen binding molecule formats" (New York Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: CANON U.S.A., INC., THE BRIGHAM AND WOMEN'S HOSPITAL INC., THE GENERAL HOSPITAL CORPORATION FILES APPLICATION FOR "LOCALIZATION AND TARGETING OF SMALL PULMONARY LESIONS"
Published:
April 23, 2024
by U.S. Fed News
|
Ask us about our Tissue & Hygiene market view